| P50 | author | Alison H Harrill | Q58794308 |
| P2093 | author name string | D M Spencer | |
| | T K Kishimoto | |
| | B K Park | |
| | P B Watkins | |
| | D S Pisetsky | |
| | J Roach | |
| | D J Antoine | |
| | C L Kurtz | |
| | I Fier | |
| | J S Eaddy | |
| P2860 | cites work | Identification of tissue-specific microRNAs from mouse | Q27860892 |
| | Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity | Q31975827 |
| | Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats | Q33241234 |
| | Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial | Q33389032 |
| | Complications of heparin administration in normal individuals | Q33459870 |
| | Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group. | Q33493426 |
| | Mechanisms of immune-mediated liver injury | Q33856306 |
| | Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity | Q34024427 |
| | High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity | Q34400931 |
| | Anticoagulants and transaminase elevation | Q34514425 |
| | Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker | Q35872235 |
| | The current state of serum biomarkers of hepatotoxicity. | Q37091307 |
| | Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. | Q37633115 |
| | Infliximab-related hepatitis: discussion of a case and review of the literature. | Q37682683 |
| | Drug-induced liver injury: past, present and future. | Q37736444 |
| | Glutamate dehydrogenase: biochemical and clinical aspects of an interesting enzyme | Q39647844 |
| | Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). | Q41875540 |
| | Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury | Q43126682 |
| | High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo | Q43270651 |
| | Heparin-induced hepatotoxicity | Q43729280 |
| | Using controlled clinical trials to learn more about acute drug-induced liver injury | Q45833400 |
| | Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine | Q46525311 |
| | Biologic tolerance of two different low molecular weight heparins | Q47424643 |
| | Circulating microRNAs as potential markers of human drug-induced liver injury | Q60609564 |
| | Serum aminotransferases after low-dose heparin treatment. Short communication | Q67387034 |
| | Effects of heparin in vivo on lysosomal enzymes in rat plasma | Q68568178 |
| | Heparin treatment of deep vein thrombosis. Effects and complications after continuous or intermittent heparin administration | Q70223156 |
| | Toxicity of heparin in isolated rat hepatocytes | Q70580855 |
| | Hypertransaminasemia with subcutaneous heparin therapy | Q71066605 |
| | Transaminase elevations in patients receiving bovine or porcine heparin | Q71317765 |
| | Effects of short-term low-dose heparin administration on biochemical parameters of bone turnover | Q72555460 |
| | Role of Toll-like receptors in HMGB1 release from macrophages | Q81038356 |
| | Clinically significant liver injury in patients treated with natalizumab | Q82935643 |
| | M118--a rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes | Q84845450 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 214-220 | |
| P577 | publication date | 2012-06-27 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers | |
| P478 | volume | 92 | |